Glucose Test

Your fasting glucose level is one of the most direct windows into how well your body handles its primary fuel. Even small, sustained elevations in this number, well below the threshold for a diabetes diagnosis, are tied to meaningfully higher risks of heart disease, certain cancers, and earlier death. A study pooling data from over 820,000 people found that those with impaired fasting glucose (100 to 125 mg/dL) had a 17% higher risk of dying from vascular causes and a 13% higher risk of dying from cancer compared to those in the 70 to 100 mg/dL range.

The trouble is that glucose problems develop silently. Type 2 diabetes typically begins 4 to 7 years before anyone makes the diagnosis, and complications can start during that invisible window. Right now, about one in four American adults with type 2 diabetes does not know they have it. Knowing your fasting glucose, and tracking how it changes over time, puts you ahead of a problem that rewards early action more than almost any other metabolic issue.

What Glucose Tells You

Glucose (a six-carbon sugar, chemical formula C6H12O6) is the obligate energy source for your brain and red blood cells, meaning they cannot run on anything else. Your liver is the main source of the glucose circulating in your blood when you have not eaten recently. It releases stored glucose and also manufactures new glucose from building blocks like lactate and amino acids. After you eat, glucose from digested carbohydrates floods your bloodstream, and your pancreas secretes insulin to usher that glucose into muscle and fat cells for use or storage.

A fasting glucose measurement captures the balance between how much glucose your liver is producing and how effectively insulin is suppressing that production. When this system starts to break down, either because your cells stop responding well to insulin (a condition called insulin resistance) or because your pancreas can no longer keep up with demand, fasting glucose rises. By the time that number crosses the diabetes threshold, the underlying metabolic problem has usually been building for years.

Heart Disease Risk

The relationship between glucose and cardiovascular disease is continuous, not a cliff edge that appears at the diabetes cutoff. A meta-analysis of 102 prospective studies found that for every 1 mmol/L (18 mg/dL) rise in fasting glucose above 100 mg/dL, the risk of coronary heart disease increased by 12%. People with fasting glucose at or above 126 mg/dL (the diabetes threshold) had roughly 1.9 times the risk of dying from vascular causes compared to those in the 70 to 100 mg/dL range, even after excluding people with known diabetes.

A separate analysis of over 1.6 million people confirmed that even the "prediabetic" range carries real risk. People with impaired fasting glucose (100 to 125 mg/dL) had a 13% higher rate of cardiovascular events and a 13% higher rate of death from any cause compared to those with normal glucose. These associations held after adjusting for standard risk factors like blood pressure, cholesterol, and smoking.

The largest single-population study, following over 12.4 million Korean adults, found that the optimal fasting glucose for the lowest mortality was 80 to 94 mg/dL across all age groups. Each 18 mg/dL increase above 100 mg/dL raised mortality risk by 13%. The effect was strongest in younger adults: for those aged 18 to 34, a fasting glucose of 100 to 125 mg/dL was associated with a 30% higher mortality risk, compared to 10% in adults aged 75 and older.

Cancer Associations

Elevated glucose is linked to cancer risk independently of body weight. The Metabolic Syndrome and Cancer Project, which tracked nearly 550,000 Europeans for about 10 years, found that each 1 mmol/L (18 mg/dL) increase in glucose was associated with a 5% higher risk of developing cancer in men and an 11% higher risk in women, after adjusting for BMI and smoking. Fatal cancer risk was even more strongly tied to glucose: 15% higher per unit increase in men and 21% higher in women.

Specific cancers showed even stronger connections. In a Swedish study of over 64,000 people, those in the top quarter of fasting glucose had roughly 2.5 times the risk of pancreatic cancer and nearly double the risk of endometrial cancer compared to those in the bottom quarter. The UK Biobank study of over 476,000 participants confirmed that diabetes was associated with increased risk of stomach, liver, bladder, endometrial, and lung cancers.

Kidney and Nerve Damage

Chronic glucose elevation damages the small blood vessels that feed your kidneys, eyes, and nerves. A genetic analysis of over 117,000 Danish individuals confirmed that glucose is a direct cause of these complications, not just a bystander. For every 1 mmol/L (18 mg/dL) of genetically predicted higher glucose, the risk of eye damage (retinopathy) roughly doubled, nerve damage (neuropathy) increased by about 2.2 times, and kidney damage (diabetic nephropathy) increased by about 1.6 times.

Among over 183,000 people with diabetes, those with signs of kidney protein leakage had major kidney events at a rate of 15.4%, and optimal on-treatment glucose targets were higher (126 to 160 mg/dL) for people who already had kidney damage, versus 100 to 126 mg/dL for those without it. This J-shaped pattern, where pushing glucose too low can also cause harm in kidney disease, is an important nuance for anyone monitoring their levels.

Reference Ranges

Your age, sex, and ethnicity can slightly shift what is "normal" for you. Men tend to run about 2 mg/dL higher than women, and fasting glucose rises by roughly 1 mg/dL per decade starting in your 30s. Hispanic Americans tend to have somewhat higher fasting glucose (median around 96 mg/dL) than non-Hispanic White Americans (median around 95 mg/dL) or non-Hispanic Black Americans (median around 93 mg/dL). These are small differences, but they can matter near diagnostic cutoffs.

These tiers are drawn from ADA guidelines and large population studies. Your lab may use slightly different assays and cutpoints. The World Health Organization uses a higher lower threshold for prediabetes (110 mg/dL instead of 100 mg/dL), so some people classified as prediabetic by ADA criteria would be considered normal by WHO criteria. Compare your results within the same lab over time for the most meaningful trend.

Why One Reading Is Not Enough

Glucose is one of the more variable blood markers you can test. The within-person coefficient of variation is about 4.8 to 5.7%, which means that if your true fasting glucose is 126 mg/dL (the diabetes cutoff), a single blood draw could plausibly read anywhere from 110 to 142 mg/dL just due to normal biological and analytical fluctuation. This is why the ADA requires a confirmatory test before diagnosing diabetes based on a fasting glucose alone.

For someone focused on prevention, the trajectory of your glucose over months and years matters far more than any single snapshot. A fasting glucose that was 85 two years ago and is now 98 is telling you something, even though both readings are "normal." That upward drift signals that your metabolic reserve is shrinking. Get a baseline reading, retest in 3 to 6 months if you are making dietary or exercise changes, and track at least annually thereafter. If your level is in the prediabetic range, test every 6 months to gauge whether your interventions are actually working.

Long-term glucose variability itself carries risk. People with type 2 diabetes whose fasting glucose swings widely from visit to visit have 50 to 300% higher rates of dangerous blood sugar crashes (hypoglycemia) and increased cardiovascular events, independent of their average level. Stability matters, not just the number.

When Results Can Be Misleading

A single glucose reading can be thrown off by several common situations, leading you to overreact or, worse, to be falsely reassured.

• Time of day: Fasting glucose drops throughout the day. A blood draw at 3 PM may read 7 to 8 mg/dL lower than the same person's 8 AM draw. Morning readings also reflect the "dawn phenomenon," a natural cortisol-driven glucose rise that can push morning levels 13 to 24% higher than evening lows.
• Acute illness or stress: Any significant physical stressor, from a bad cold to a car accident to major surgery, triggers a hormone cascade that can spike glucose for 24 to 48 hours or longer. About 30 to 40% of people admitted for acute stroke have elevated glucose that resolves once the crisis passes. If you are testing after a recent illness, wait at least a week.
• Intense exercise: A hard sprint session or heavy lifting can transiently raise glucose through adrenaline and stored-sugar release, while moderate aerobic exercise typically lowers it for up to 48 hours afterward. Time your blood draw to reflect your baseline, not the aftermath of yesterday's workout.
• Inadequate fasting: You need at least 8 hours of fasting for the reading to be interpretable. Even a small snack or calorie-containing beverage will invalidate the result.